Logo image
Novel STMN2 variant linked to amyotrophic lateral sclerosis risk and clinical phenotype
Journal article   Open access   Peer reviewed

Novel STMN2 variant linked to amyotrophic lateral sclerosis risk and clinical phenotype

F. Theunissen, R.S. Anderton, F.L. Mastaglia, L.L. Flynn, S.J. Winter, I. James, R. Bedlack, S. Hodgetts, S. Fletcher, S.D. Wilton, …
Frontiers in Aging Neuroscience, Vol.13, 658226
2021
pdf
STMN21.94 MBDownloadView
Published (Version of Record)CC BY V4.0 Open Access

Abstract

Objective: There is a critical need to establish genetic markers that explain the complex phenotypes and pathogenicity of ALS. This study identified a polymorphism in the Stathmin-2 gene and investigated its association with sporadic ALS (sALS) disease risk, age-of onset and survival duration. Methods: The candidate CA repeat was systematically analyzed using PCR, Sanger sequencing and high throughput capillary separation for genotyping. Stathmin-2 expression was investigated using RT-PCR in patient olfactory neurosphere-derived (ONS) cells and RNA sequencing in laser-captured spinal motor neurons. Results: In a case-control analysis of a combined North American sALS cohort (n = 321) and population control group (n = 332), long/long CA genotypes were significantly associated with disease risk (p = 0.042), and most strongly when one allele was a 24 CA repeat (p = 0.0023). In addition, longer CA allele length was associated with earlier age-of-onset (p = 0.039), and shorter survival duration in bulbar-onset cases (p = 0.006). In an Australian longitudinal sALS cohort (n = 67), ALS functional rating scale scores were significantly lower in carriers of the long/long genotype (p = 0.034). Stathmin-2 mRNA expression was reduced in sporadic patient ONS cells. Additionally, sALS patients and controls exhibited variable expression of Stathmin-2 mRNA according to CA genotype in laser-captured spinal motor neurons. Conclusions: We report a novel non-coding CA repeat in Stathmin-2 which is associated with sALS disease risk and has disease modifying effects. The potential value of this variant as a disease marker and tool for cohort enrichment in clinical trials warrants further investigation.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

163 File views/ downloads
142 Record Views

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
International collaboration
Citation topics
1 Clinical & Life Sciences
1.52 Neurodegenerative Diseases
1.52.765 ALS Mechanisms
Web Of Science research areas
Geriatrics & Gerontology
Neurosciences
ESI research areas
Neuroscience & Behavior
Logo image